pfizer glp-1 news Phase IIb Data Support Monthly Dosing for Obesity Pfizer is pulling back the
Description
In this review, we highlight past and recent results describing how dietary manipulation of the gut microbiota, using nutrients or specific microbes, can stimulate GLP-1 secretion in rodents and humans
Even so, effective treatments for insulin resistance have been developed
Clinical studies have supported this with GLP-1 receptor analogs such as liraglutide and semaglutide in both weight loss and weight loss maintenance trials
Tepper S, Ashina M, Reuter U, et al
10.1016/j.chom.2016.03.004 83 SachsG.ShinJ
After providing glucose, monitor the patient and allow time for the blood glucose to stabilize before resuming activity
